Further investigations are needed to elucidate the functional role of FST in tumor biology and whether it presents a candidate target for small-molecule inhibition or is itself a molecule to enhance therapeutic response, ultimately improving health outcomes for cancer patients. This evidence concerns the gene FST and cancer.